A snapshot of biologic drug development

Since the approval of insulin as the first recombinant therapeutic protein, the prominence of biologic therapies in drug development has grown significantly. Many modalities beyond traditional biologics are now being developed or explored for various indications with significant unmet medical needs....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Human & experimental toxicology 2015-12, Vol.34 (12), p.1279
Hauptverfasser:	Andrews, L, Ralston, S, Blomme, E, Barnhart, K
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Biological products Disease Drug dosages Insulin Monoclonal antibodies Proteins Toxicology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!